Tumor microenvironment and progression of pancreatic cancer

Experimental Oncology

Volumn 32, Issue 3, 2010, Pages 128-131

  Erkan, M ^a   Reiser Erkan, C ^a   Michalski, C W ^a   Kleeff, J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Extracellular matrix; Microenvironment; Pancreatic cancer

Indexed keywords

BARRETT ESOPHAGUS; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CHRONIC PANCREATITIS; COLON CANCER; ENTERITIS; ESOPHAGUS CANCER; EXTRACELLULAR MATRIX; LIVER CANCER; PANCREAS ADENOCARCINOMA; PANCREATITIS; REVIEW; TUMOR MICROENVIRONMENT;

ADENOCARCINOMA; ANIMALS; DISEASE PROGRESSION; HUMANS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 77957726424     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998; 43: 128-33.
2. Bachem MG, Schneider E, Gross H, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998; 115: 421-32.
3. Erkan M, Weis N, Pan Z, et al. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer 2010; 9: 88.
4. Erkan M, Kleeff J, Gorbachevski A, et al. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 2007; 132: 1447-64. (Pubitemid 46627568)
5. Erkan M, Reiser-Erkan C, Michalski CW, et al. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia 2009; 11: 497-508.
6. Erkan M, Michalski CW, Rieder S, et al. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 2008; 6: 1155-61.
7. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53: 4727-35.
8. Compagni A, Wilgenbus P, Impagnatiello MA, et al. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 2000; 60: 7163-9. (Pubitemid 32059199)
9. Matsuo Y, Ochi N, Sawai H, et al. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 2009; 124: 853-61.
10. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-60.
11. Koong AC, Mehta VK, Le QT, et al. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 2000; 48: 919-22.
12. Reiser-Erkan C, Erkan M, Pan Z, et al. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 2008; 7: 1352-9.
13. Schwarte-Waldhoff I, Volpert OV, Bouck NP, et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci U S A 2000; 97: 9624-9. (Pubitemid 30650826)
14. Salvioli B, Bovara M, Barbara G, et al. Neurology and neuropathology of the pancreatic innervation. Jop 2002; 3: 26-33.
15. Ceyhan GO, Schafer KH, Kerscher AG, et al. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann Surg 2010; 251: 923-31.
16. Farrar JT, Portenoy RK. Neuropathic cancer pain: the role of adjuvant analgesics. Oncology (Williston Park) 2001; 15: 1435-42, 1445; discussion 1445, 1450-3.
17. Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Gut 2007; 56: 534-44. (Pubitemid 46580510)
18. Ceyhan GO, Deucker S, Demir IE, et al. Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis. Lab Invest 2009; 89: 347-61.
19. Michalski CW, Oti FE, Erkan M, et al. Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer 2008; 122: 742-50.
20. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-45.
21. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315: 1650-9.
22. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6: 24-37. (Pubitemid 43053650)
23. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71-8.
24. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-55. (Pubitemid 35223554)
25. Michalski CW, Maier M, Erkan M, et al. Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells. PLoS One 2008; 3: e1701.
26. Esposito I, Menicagli M, Funel N, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004; 57: 630-6. (Pubitemid 38725766)
27. Michalski CW, Gorbachevski A, Erkan M, et al. Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis. J Transl Med 2007; 5: 63. (Pubitemid 351248080)
28. Aoyagi Y, Oda T, Kinoshita T, et al. Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br J Cancer 2004; 91: 1316-26. (Pubitemid 39424793)
29. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1: 46-54.
30. Lunevicius R, Nakanishi H, Ito S, et al. Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol 2001; 127: 193-9. (Pubitemid 32449071)